Effect of Lower Pneumoperitoneum Pressure During Laparoscopic and Robotic Hysterectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-03

Study Completion Date

2021-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

With the limited evidence that lower pneumoperitoneum pressures improve postoperative pain in laparoscopic or robotic hysterectomy for benign indications, we would like to determine if we can both further validate this idea but also show that it has minimal effect on physician satisfaction performing the surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pain With Differing Insufflation Pressures During Laparoscopic Hysterectomy

NCT06508814

Post Operative Pain

RECRUITING NA

Safety, Efficacy and Operability of Using the New Tissue Containment System During Laprascopic Hysterectomy

NCT04423172

Gynecologic Surgery

UNKNOWN NA

Randomized Clinical Trial Comparing Conventional Laparoscopic and Robot-Assisted Laparoscopic Hysterectomy

NCT02118974

Menorrhagia Pelvic Pain Hysterectomy

COMPLETED NA

Postoperative Pain After Total Laparoscopic Hysterectomy: a Comparison of Single-port and Three-port Laparoscopy

NCT02390804

Uterine Disease Postoperative Pain

COMPLETED NA

Study Comparing Conventional vs. Robotic-assisted Laparoscopic Hysterectomy

NCT00485355

Uterine Fibroids, Menorrhagia, Endometriosis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Minimally invasive hysterectomy, including conventional laparoscopic and robotic-assisted hysterectomy, is a commonly performed gynecologic surgery that universally results in postoperative pain for patients. Opioid medications are helpful to control postoperative pain and are routinely given to women who undergo minimally invasive hysterectomy. However, opioid abuse is on the rise in the United States, and there is increased awareness of misuse leading to abuse, overdose, and chronic opioid use. In addition to narcotic usage, postoperative pain also has negative effects on patient satisfaction and length of stay in the post-anesthesia care unit (PACU) leading to potential hospital admission. There is existing evidence that reducing the pressure used to create the pneumoperitoneum during laparoscopic surgery may affect pain scores that patients endorse in the PACU. Due to improved postoperative pain, patients may have decreased opioid use in the PACU and at home, shorter hospital stay, and improved overall patient satisfaction. If lower pneumoperitoneum pressures during laparoscopic surgery can be shown to reduce postoperative pain, then the ultimate question becomes whether there is ability to adapt this practice of using lower pressures to maintain pneumoperitoneum. It is unclear whether physician satisfaction will be affected.

There are several publications investigating the effect of lower pneumoperitoneum pressures on postoperative pain. A systematic review in 2016 included 238 patients (three RCTs), showed pneumoperitoneum pressures of 8mmHg had a statistically significant although minimal decrease in postoperative pain compared to 12mmHg, although lower pressures were associated with worse visualization. The authors concluded that the systematic review was inconclusive and further studies were necessary. A randomized pilot study with 60 patients comparing low pressure (7mmHg) using the AirSeal System versus standard insufflation (15mmHg), showed lower postoperative shoulder pain in the group with lower pressure using the AirSeal system. Two abstracts in the Journal of Minimally Invasive Gynecology present retrospective studies showing decreased postoperative pain with lower pneumoperitoneum pressure. The first abstract is from 2015, included a sample size of 170 patients who underwent benign robotic gynecologic surgery, 85 patients in each arm (12mmHg and 15mmHg). They showed no difference in median recovery time in the PACU and significantly lower median first pain score (5 vs 6, p=.04). The second abstract is from 2018 and included a sample size of 598 patients who underwent benign robotic gynecologic surgery, 99 patients in 15mmHg arm, 100 patients in 12mmHg arm, 99 patients in 10mmHg arm, and 300 patients in 8mmHg arm. They showed lower initial pain scores with each degree of lower pressure (5.9 vs 5.4 vs 4.4 vs 3.8, p=\<.0001) and shorter hospital stays with lower pressures. They showed no difference in operative times or blood loss in the four arms. Similar studies have been done with cholecystectomy patients that have shown improved postoperative shoulder pain with lower pneumoperitoneum pressures. There is also an ongoing clinical trial that is still recruiting patients that is studying this similar comparison using 9mmHg vs 15mmHg with and without the AirSeal system.

However, the literature summarized here has never included blinding the intervention of lower pneumoperitoneum pressure to the surgeon to determine awareness of pressure and its effect on visualization and physician satisfaction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hysterectomy Pneumoperitoneum

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Three arms including those with pneumoperitoneum pressure of 15mmgHg versus 12mmgHg vs 10 mmHg during laparoscopic or robotic hysterectomy for benign indications.

Primary Study Purpose

OTHER

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Research coordinator will have randomized the patient into one of the 3 arms. The randomized pneumoperitoneum pressure will be set for the surgical procedure and blinded to the surgeon and first assistant, either fellow or resident.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1. Pneumoperitoneum pressure = 15mmHg

1\. Pneumoperitoneum will be set at 15mmHg

Group Type ACTIVE_COMPARATOR

Pneumoperitoneum pressure = 15mmHg

Intervention Type OTHER

Randomized pneumoperitoneum 1

2. Pneumoperitoneum pressure = 12mmHg

2.Pneumoperitoneum will be set at 12mmHg

Group Type ACTIVE_COMPARATOR

Pneumoperitoneum pressure = 12mm Hg

Intervention Type OTHER

Randomized pneumoperitoneum 2

3. Pneumoperitoneum set at 10mmHg

3\. Pneumoperitoneum will be set at 10mmHg

Group Type ACTIVE_COMPARATOR

Pneumoperitoneum pressure = 10mmHg

Intervention Type OTHER

Randomized pneumoperitoneum 3

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pneumoperitoneum pressure = 15mmHg

Randomized pneumoperitoneum 1

Intervention Type OTHER

Pneumoperitoneum pressure = 12mm Hg

Randomized pneumoperitoneum 2

Intervention Type OTHER

Pneumoperitoneum pressure = 10mmHg

Randomized pneumoperitoneum 3

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* female patients
* greater than or equal to 18 years old
* English-speaking
* undergoing laparoscopic or robotic total hysterectomy for benign indications by one of the two minimally invasive gynecologic surgeons at Banner University Medical Center - Phoenix

Exclusion Criteria

* patients with body max index \>35
* American Society of Anesthesiologists (ASA) score III or IV
* preoperative uterine weight estimated to be greater than 500gm (measured by sonography and using the following formula: length x width x anteroposterior diameter x 0.52)
* patients on chronic opioids for chronic pain (defined as \> 3 months regular opioid use)
* patients who refuse participation in the study
* patients who do not provide informed consent

Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes